Actemra

Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup
Roche torches a mountain of biobucks, sweeping out a roster of R&D programs in the latest pipeline cleanup
Endpoints
Roche
earnings
R&D
RG6125
Actemra
RG7155
Flag link:
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Roche's Child Arthritis Drug's New Formulation Gets FDA Nod
Yahoo/Zacks.com
Roche
Genentech
FDA
Actemra
systematic juvenile idiopathic arthritis
Flag link:
New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
RAPS.org
Roche
Actemra
FDA
giant cell arteritis
tocilizumab
Flag link:
Could an old Roche arthritis med become a pioneering PAH treatment?
Could an old Roche arthritis med become a pioneering PAH treatment?
BioPharma Dive
Roche
PAH
pulmonary arterial hypertension
tocilizumab
Actemra
Flag link:
Roche’s Arthritis Blockbuster Holds Promise for Diabetes
Roche’s Arthritis Blockbuster Holds Promise for Diabetes
Bloomberg
Roche
type 1 diabetes
Actemra
Flag link:
Abbott, Roche Issue Dueling Arthritis Drug Reports
Abbott, Roche Issue Dueling Arthritis Drug Reports
Investors.com
Roche
rheumatoid arthritis
Abbott Laboratories
Humira
Actemra
Flag link:
Roche Scores Important Win With Actemra
Roche Scores Important Win With Actemra
Seeking Alpha
Roche
Actemra
arthritis
rheumatoid arthritis
Flag link:
Roche Wins Broader U.S. Approval for Actemra Arthritis Drug
Roche Wins Broader U.S. Approval for Actemra Arthritis Drug
Bloomberg
Actemra
Roche
arthritis
Flag link:
Roche seeks OK for juvenile Actemra use
Roche seeks OK for juvenile Actemra use
Fierce Pharma
Roche
pediatrics
Actemra
juvenile arthritis
Flag link:
Roche Wins U.S. Approval for Arthritis Drug Actemra
Roche Wins U.S. Approval for Arthritis Drug Actemra
BusinessWeek
Roche
Actemra
Flag link:
Roche's Actemra successful in arthritis study
Roche's Actemra successful in arthritis study
Reuters
arthritis
Actemra
Roche
Flag link:
Phase III Study Showed Two Years of ACTEMRA® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission
Phase III Study Showed Two Years of ACTEMRA® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission
Reuters
Actemra
tocilizumab
rheumatoid arthritis
Genentech
Flag link:
Roche set to unveil new rheumatism drug
Roche set to unveil new rheumatism drug
Hays Pharma, UK
Roche
rheumatoid arthritis
Actemra
Flag link:
Roche: safety concerns threaten future blockbuster
Roche: safety concerns threaten future blockbuster
Pharmaceutical Business Review
Roche
Actemra
rheumatoid arthritis
Flag link:
Chugai Defends Actemra Drug After Report of Deaths
Chugai Defends Actemra Drug After Report of Deaths
Bloomberg
Chugai
Actemra
arthritis
Flag link: